Ruplizumab
Ruplizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of Antova.
| Trade Name | Ruplizumab |
| Generic | Ruplizumab |
| Ruplizumab Other Names | Ruplizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in thrombocytopenia, systemic lupus erythematosus, transplant (rejection), blood (blood forming organ disorders, unspecified), and multiple sclerosis.
How Ruplizumab works
Ruplizumab is an anti-CD40L monoclonal antibody. The binding of CD40 to its ligand, CD40L, is a critical element in T cell activation. In systemic lupus erythematosus, CD40L is over-expressed on T cells, B cells, and monocytes.
Innovators Monograph
You find simplified version here Ruplizumab
